Biotech entity

Caroline Waldron

Person

pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Anne Lockwood, the most common co-covered peer. The tracked stories average 4 original sources each. Caroline Waldron appears in 1 tracked Biotech story from February 26, 2026.

Last mentioned: Feb 26, 2026

Entity pulse

Recent coverage · Caroline Waldron

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Caroline Waldron

pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Anne Lockwood, the most common co-covered peer. The tracked stories average 4 original sources each. Caroline Waldron appears in 1 tracked Biotech story from February 26, 2026.

Stories tracked
1
Sources per story
4

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Caroline Waldron. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. GSS Strategic Review

    Board outlines steps to address unsustainable cash burn levels.

  2. H1 FY26 Earnings Release

    Genetic Signatures and ClearView Wealth report half-year results.

  3. Zurich Acquisition Announced

    ClearView Wealth enters Scheme Implementation Deed with Zurich.

Stories mentioning Caroline Waldron 1

Pharma Neutral

Genetic Signatures Faces 'Unsustainable' Cash Burn Amid H1 Revenue Growth

Genetic Signatures (ASX:GSS) reported a modest revenue increase for H1 FY26 but warned that its current cash burn rate is unsustainable, prompting immediate board intervention. Meanwhile, the broader ASX landscape saw significant consolidation as ClearView Wealth (ASX:CVW) entered a definitive acquisition agreement with Zurich following a period of strong profitability.

4 sources

Caroline Waldron is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.